Bio-Techne Corp (TECH)
71.88
-0.64
(-0.88%)
USD |
NASDAQ |
Mar 18, 16:00
71.88
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Price to Book Value: 5.754 for March 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 18, 2024 | 5.754 |
March 15, 2024 | 5.806 |
March 14, 2024 | 5.702 |
March 13, 2024 | 5.803 |
March 12, 2024 | 5.934 |
March 11, 2024 | 6.014 |
March 08, 2024 | 6.171 |
March 07, 2024 | 6.159 |
March 06, 2024 | 5.978 |
March 05, 2024 | 5.876 |
March 04, 2024 | 5.994 |
March 01, 2024 | 5.954 |
February 29, 2024 | 5.890 |
February 28, 2024 | 5.955 |
February 27, 2024 | 5.861 |
February 26, 2024 | 5.757 |
February 23, 2024 | 5.734 |
February 22, 2024 | 5.745 |
February 21, 2024 | 5.742 |
February 20, 2024 | 5.630 |
February 16, 2024 | 5.733 |
February 15, 2024 | 5.705 |
February 14, 2024 | 5.613 |
February 13, 2024 | 5.405 |
February 12, 2024 | 5.600 |
Date | Value |
---|---|
February 09, 2024 | 5.440 |
February 08, 2024 | 5.442 |
February 07, 2024 | 5.312 |
February 06, 2024 | 5.393 |
February 05, 2024 | 5.345 |
February 02, 2024 | 5.282 |
February 01, 2024 | 5.485 |
January 31, 2024 | 5.628 |
January 30, 2024 | 5.819 |
January 29, 2024 | 5.824 |
January 26, 2024 | 5.812 |
January 25, 2024 | 5.692 |
January 24, 2024 | 5.687 |
January 23, 2024 | 5.800 |
January 22, 2024 | 5.764 |
January 19, 2024 | 5.628 |
January 18, 2024 | 5.591 |
January 17, 2024 | 5.589 |
January 16, 2024 | 5.716 |
January 12, 2024 | 5.776 |
January 11, 2024 | 5.853 |
January 10, 2024 | 5.854 |
January 09, 2024 | 5.761 |
January 08, 2024 | 5.835 |
January 05, 2024 | 5.689 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.182
Minimum
Nov 01 2023
13.53
Maximum
Sep 24 2021
7.787
Average
7.075
Median
Jan 05 2023
Price to Book Value Benchmarks
Agilent Technologies Inc | 6.919 |
Revvity Inc | 1.634 |
Twist Bioscience Corp | 3.315 |
AIM ImmunoTech Inc | 0.8359 |
Protalix BioTherapeutics Inc | 2.764 |
Price to Book Value Related Metrics
PE Ratio | 52.09 |
PS Ratio | 10.13 |
Price to Free Cash Flow | 51.48 |
Price | 71.88 |
Earnings Yield | 1.92% |
Market Cap | 11.30B |
Operating PE Ratio | 44.52 |
Normalized PE Ratio | 52.14 |